Acute Kidney Injury | CHOP Research Institute

Dr. Fitzgerald's research focuses on the impact of pediatric sepsis on renal dysfunction. She examines biomarkers that may be helpful in predicting renal dysfunction in septic acute kidney injury, and the impact of resuscitative therapies and pharmacometrics in sepsis on the development of sepsis-related renal dysfunction.

E-mail:

fitzgeraldj [at] chop.edu

Optimizing Vancomycin Therapy in Children

Vancomycin is a commonly administered antibiotic in critically ill children, but it can have unwanted side effects on the kidney (acute kidney injury).

Kristin J. McKenna, MD, MPH

Dr. McKenna has an interest in congenital renal and genitourinary anomalies, acute kidney injury and chronic renal insufficiency in the neonate.

E-mail:

mckennakj [at] chop.edu

MIS-C Study, Hartwell Investigator, Lady Barbara Colyton Prize for Autoimmune Research, Brain Tumor Biology, Acute Kidney Injury

Published on

Dec 4, 2020

in Cornerstone Blog

This week’s roundup features CHOP’s participation in a multi-institutional MIS-C research study — the first to provide long-term outcome data.

Daniella Levy-Erez, MD

Dr. Levy-Erez's research is focused on the discovery of immune urinary biomarkers among children developing acute kidney injury. She is studying both a unique population of immune-compromised children after hematopoietic stem cell transplantation (HSCT) as well as children who have an intact immune system who develop acute kidney injury after cardiac bypass surgery.

E-mail:

levyerezd [at] chop.edu

Kevin Downes, MD

The research interests of Dr. Downes focus on antimicrobial clinical pharmacology and pharmacoepidemiology in children with a goal to identify novel approaches to optimize efficacy, minimize toxicity, and limit antimicrobial resistance from antibiotics.

E-mail:

downeskj [at] chop.edu